Quanterix files Form 3 for Chief Commercial Officer James Edward Gute JrPUBT·Aug 19 at 10:38 AMQTRX+4.26%
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood TestMarket Beat·Aug 16 at 06:02 PMQTRX+4.26%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Aug 14 at 09:06 PMOBX-1.58%QTRX+4.26%
Quanterix director William P. Donnelly reports purchase of USD 286,709 in common sharesPUBT·Aug 14 at 08:04 PMQTRX+4.26%
QTRX: Diagnostics and clinical trials growth, new leadership, and synergy gains drive optimism for 2024Quartr·Aug 12 at 06:25 PMAKYA0.00%QTRX+4.26%
Quanterix Warns of Broad Risk Exposure Despite No New Material Changes in Latest 10-QTip Ranks·Aug 11 at 06:01 AMQTRX+4.26%
Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q SummaryTradingView·Aug 10 at 12:41 PMQTRX+4.26%AKYA0.00%
QTRX: Revenue up 34% year-over-year, but 2026 outlook lowered amid market softness and execution challengesQuartr·Aug 10 at 12:16 PMQTRX+4.26%
